NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Cancer Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Cancer Gene Therapy Cell Biology



Peking Union Medical College details research in cancer gene therapy cell biology



September 23rd, 2008

A report, 'Effect of Ad-TIMP3 on biologic behavior of choriocarcinoma cells in vitro,' is newly published data in The Journal of Reproductive Medicine. "To investigate the effect of adenovirus delivered tissue inhibitor of metalloproteinases-3 (Ad-TIMP3) on the biologic behavior of choriocarcinoma cells in vitro and to evaluate its potential application in choriocarcinoma gene therapy. An adenovirus expressing TIMP3 (Ad-TIMP3) was transferred into choriocarcinoma cells jeg-3 and bewo," researchers in Beijing, People's Republic of China report.

"The mRNA and protein expression of TIMP3 were detected by reverse transcriptase polymerase chain reaction and Western...


Source: Cancer Weekly (2008-09-23)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login